{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:52:39Z","timestamp":1760953959749},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Brazilian National Research Council"},{"name":"Research Foundation of Pernambuco State"},{"name":"National Institute for Science and Technology in Pharmaceutical Innovation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.imlet.2018.03.011","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T16:29:30Z","timestamp":1522168170000},"page":"12-16","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations"],"prefix":"10.1016","volume":"198","author":[{"given":"Andr\u00e9a Tavares","family":"Dantas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson Rodrigues de","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Clara Pinheiro Duarte","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina Ferraz","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla Stela Santana de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique de Ata\u00edde","family":"Mariz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelly Cristiny","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moacyr Jesus Barreto de Melo","family":"Rego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan da Rocha","family":"Pitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela Luzia Branco Pinto","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00edra Galdino da Rocha","family":"Pitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.imlet.2018.03.011_bib0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","article-title":"Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis","volume":"10","author":"Baraut","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.imlet.2018.03.011_bib0010","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1684\/ecn.2013.0325","article-title":"T cell abnormalities in systemic sclerosis with a focus on Th17 cells","volume":"23","author":"Brembilla","year":"2012","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.imlet.2018.03.011_bib0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clim.2016.09.004","article-title":"The magnitude of cytokine production by stimulated CD56(+) cells is associated with early stages of systemic sclerosis","volume":"173","author":"Cossu","year":"2016","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2018.03.011_bib0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780350111","article-title":"Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma","volume":"35","author":"Needleman","year":"1992","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.imlet.2018.03.011_bib0025","first-page":"328","article-title":"Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis","volume":"24","author":"Hasegawa","year":"1997","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.imlet.2018.03.011_bib0030","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2249.2004.02642.x","article-title":"Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement","volume":"138","author":"Scala","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2018.03.011_bib0035","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2821","article-title":"Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations","volume":"11","author":"Gourh","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.imlet.2018.03.011_bib0040","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.imlet.2018.03.011_bib0045","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.imlet.2018.03.011_bib0050","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2018.03.011_bib0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0300-483X(98)00063-8","article-title":"Cytokine assays in human sera and tissues","volume":"129","author":"Bienvenu","year":"1998","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.imlet.2018.03.011_bib0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-3083.1999.00617.x","article-title":"Lymphocyte stimulation by CD3-CD28 enables detection of low T cell interferon-gamma and interleukin-4 production in rheumatoid arthritis","volume":"50","author":"Verhoef","year":"1999","journal-title":"Scand. J. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2018.03.011_bib0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/CDLI.1.3.261-268.1994","article-title":"In vitro cytokine production by normal human peripheral blood mononuclear cells as a measure of immunocompetence or the state of activation","volume":"1","author":"Friberg","year":"1994","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2018.03.011_bib0070","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/CDLI.5.1.78-81.1998","article-title":"Cytokine production in cell culture by peripheral blood mononuclear cells from immunocompetent hosts","volume":"5","author":"Katial","year":"1998","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2018.03.011_bib0075","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1128\/CDLI.7.6.920-924.2000","article-title":"Measurement of cytokine secretion, intracellular protein expression, and mRNA in resting and stimulated peripheral blood mononuclear cells","volume":"7","author":"Sullivan","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2018.03.011_bib0080","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0090-1229(92)90158-K","article-title":"Cytokine production and serum levels in systemic sclerosis","volume":"65","author":"Kantor","year":"1992","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"3","key":"10.1016\/j.imlet.2018.03.011_bib0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1023\/A:1011024313525","article-title":"Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation","volume":"21","author":"Valentini","year":"2001","journal-title":"J. Clin. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2018.03.011_bib0090","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.imlet.2018.03.011_bib0095","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.autrev.2010.09.016","article-title":"Fibrosis and immune dysregulation in systemic sclerosis","volume":"10","author":"Chizzolini","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.imlet.2018.03.011_bib0100","first-page":"291","article-title":"Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1","volume":"23","author":"Giacomelli","year":"1996","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.imlet.2018.03.011_bib0105","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/rheumatology\/38.7.612","article-title":"Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis","volume":"38","author":"Hasegawa","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.imlet.2018.03.011_bib0110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/03009740802572467","article-title":"Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion","volume":"38","author":"van Lieshout","year":"2009","journal-title":"Scand. J. Rheumatol."},{"issue":"9","key":"10.1016\/j.imlet.2018.03.011_bib0115","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/art.11129","article-title":"Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha","volume":"48","author":"Chizzolini","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.imlet.2018.03.011_bib0120","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3109\/01902149509050842","article-title":"Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression","volume":"21","author":"Gurujeyalakshmi","year":"1995","journal-title":"Exp. Lung Res."},{"issue":"2","key":"10.1016\/j.imlet.2018.03.011_bib0125","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.37738","article-title":"Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts","volume":"65","author":"Hugle","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.imlet.2018.03.011_bib0130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/03009742.2011.585349","article-title":"IFN-gamma and TNF-alpha induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls","volume":"40","author":"Antonelli","year":"2011","journal-title":"Scand. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.imlet.2018.03.011_bib0135","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1186\/ar3363","article-title":"Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity","volume":"13","author":"Wu","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.imlet.2018.03.011_bib0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cytogfr.2012.04.003","article-title":"Interleukin-6, its role in fibrosing conditions","volume":"23","author":"O'Reilly","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"10.1016\/j.imlet.2018.03.011_bib0145","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbadis.2012.09.014","article-title":"Cytokine mediated tissue fibrosis","volume":"1832","author":"Borthwick","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.imlet.2018.03.011_bib0150","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0923-1811(01)00128-1","article-title":"Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis","volume":"27","author":"Sato","year":"2001","journal-title":"J. Dermatol. Sci."},{"issue":"6","key":"10.1016\/j.imlet.2018.03.011_bib0155","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1756-185X.12290","article-title":"Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis","volume":"17","author":"Olewicz-Gawlik","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.imlet.2018.03.011_bib0160","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/08916934.2015.1054028","article-title":"Interferons and systemic sclerosis: correlation between interferon gamma and interferon-lambda 1 (IL-29)","volume":"48","author":"Dantas","year":"2015","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.imlet.2018.03.011_bib0165","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-110-6-446","article-title":"Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration","volume":"110","author":"Kahaleh","year":"1989","journal-title":"Ann. Intern. Med."},{"issue":"3\u20134","key":"10.1016\/j.imlet.2018.03.011_bib0170","first-page":"251","article-title":"The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis","volume":"36","author":"Alecu","year":"1998","journal-title":"Rom. J. Intern. Med.\u202f=\u202fRevue roumaine de medecine interne"},{"issue":"6","key":"10.1016\/j.imlet.2018.03.011_bib0175","first-page":"1252","article-title":"Increased frequency of interleukin 4 producing CD4+ and CD8+ cells in peripheral blood from patients with systemic sclerosis","volume":"28","author":"Tsuji-Yamada","year":"2001","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.imlet.2018.03.011_bib0180","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar2766","article-title":"Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients","volume":"11","author":"Schmidt","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.imlet.2018.03.011_bib0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.clim.2011.08.010","article-title":"Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis","volume":"141","author":"Divekar","year":"2011","journal-title":"Clin. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247818300440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247818300440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T07:37:16Z","timestamp":1604043436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247818300440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":37,"alternative-id":["S0165247818300440"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2018.03.011","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2018.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}